These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 21752954)
61. Superior induction of T cell responses to conserved HIV-1 regions by electroporated alphavirus replicon DNA compared to that with conventional plasmid DNA vaccine. Knudsen ML; Mbewe-Mvula A; Rosario M; Johansson DX; Kakoulidou M; Bridgeman A; Reyes-Sandoval A; Nicosia A; Ljungberg K; Hanke T; Liljeström P J Virol; 2012 Apr; 86(8):4082-90. PubMed ID: 22318135 [TBL] [Abstract][Full Text] [Related]
62. Dendritic cell mediated delivery of plasmid DNA encoding LAMP/HIV-1 Gag fusion immunogen enhances T cell epitope responses in HLA DR4 transgenic mice. Simon GG; Hu Y; Khan AM; Zhou J; Salmon J; Chikhlikar PR; Jung KO; Marques ET; August JT PLoS One; 2010 Jan; 5(1):e8574. PubMed ID: 20052293 [TBL] [Abstract][Full Text] [Related]
63. Protection against influenza virus infection in mice immunized by administration of hemagglutinin-expressing DNAs with electroporation. Kadowaki S; Chen Z; Asanuma H; Aizawa C; Kurata T; Tamura S Vaccine; 2000 Jun; 18(25):2779-88. PubMed ID: 10812219 [TBL] [Abstract][Full Text] [Related]
64. Immunogenicity of a new HIV-1 DNA construct in a BALB/c mouse model. Mahdavi M; Ebtekar M; Mahboudi F; Khorram Khorshid H; Rahbarizadeh F; Azadmanesh K; Darabi H; Pourasgari F; Hassan ZM Iran J Immunol; 2009 Dec; 6(4):163-73. PubMed ID: 20054104 [TBL] [Abstract][Full Text] [Related]
65. Adjuvantive effects of anti-4-1BB agonist Ab and 4-1BBL DNA for a HIV-1 Gag DNA vaccine: different effects on cellular and humoral immunity. Ganguly S; Liu J; Pillai VB; Mittler RS; Amara RR Vaccine; 2010 Feb; 28(5):1300-9. PubMed ID: 19944789 [TBL] [Abstract][Full Text] [Related]
66. Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses. Wang D; Christopher ME; Nagata LP; Zabielski MA; Li H; Wong JP; Samuel J J Clin Virol; 2004 Dec; 31 Suppl 1():S99-106. PubMed ID: 15567101 [TBL] [Abstract][Full Text] [Related]
67. High antibody and cellular responses induced to HIV-1 clade C envelope following DNA vaccines delivered by electroporation. Yin J; Dai A; Lecureux J; Arango T; Kutzler MA; Yan J; Lewis MG; Khan A; Sardesai NY; Montefiore D; Ruprecht R; Weiner DB; Boyer JD Vaccine; 2011 Sep; 29(39):6763-70. PubMed ID: 21195801 [TBL] [Abstract][Full Text] [Related]
68. Intramuscular immunization with a monogenic plasmid DNA tuberculosis vaccine: Enhanced immunogenicity by electroporation and co-expression of GM-CSF transgene. Zhang X; Divangahi M; Ngai P; Santosuosso M; Millar J; Zganiacz A; Wang J; Bramson J; Xing Z Vaccine; 2007 Jan; 25(7):1342-52. PubMed ID: 17052817 [TBL] [Abstract][Full Text] [Related]
69. Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys. Barouch DH; Craiu A; Kuroda MJ; Schmitz JE; Zheng XX; Santra S; Frost JD; Krivulka GR; Lifton MA; Crabbs CL; Heidecker G; Perry HC; Davies ME; Xie H; Nickerson CE; Steenbeke TD; Lord CI; Montefiori DC; Strom TB; Shiver JW; Lewis MG; Letvin NL Proc Natl Acad Sci U S A; 2000 Apr; 97(8):4192-7. PubMed ID: 10759543 [TBL] [Abstract][Full Text] [Related]
70. Modulation of cellular and humoral immune responses to a multiepitopic HIV-1 DNA vaccine by interleukin-18 DNA immunization/viral protein boost. Billaut-Mulot O; Idziorek T; Loyens M; Capron A; Bahr GM Vaccine; 2001 Apr; 19(20-22):2803-11. PubMed ID: 11282190 [TBL] [Abstract][Full Text] [Related]
71. [Protective immune responses induced by intranasal immunization with Mycoplasma pneumoniae P1C-IL-2 fusion DNA vaccine in mice]. Zhu C; Yu M; Gao S; Zeng Y; You X; Wu Y Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jun; 29(6):585-8. PubMed ID: 23746241 [TBL] [Abstract][Full Text] [Related]
72. Dose-dependent inhibition of Gag cellular immunity by Env in SIV/HIV DNA vaccinated macaques. Valentin A; Li J; Rosati M; Kulkarni V; Patel V; Jalah R; Alicea C; Reed S; Sardesai N; Berkower I; Pavlakis GN; Felber BK Hum Vaccin Immunother; 2015; 11(8):2005-11. PubMed ID: 26125521 [TBL] [Abstract][Full Text] [Related]
73. Resiquimod is a modest adjuvant for HIV-1 gag-based genetic immunization in a mouse model. Otero M; Calarota SA; Felber B; Laddy D; Pavlakis G; Boyer JD; Weiner DB Vaccine; 2004 Apr; 22(13-14):1782-90. PubMed ID: 15068862 [TBL] [Abstract][Full Text] [Related]
74. Gender differences in human immunodeficiency virus type 1-specific CD8 responses in the reproductive tract and colon following nasal peptide priming and modified vaccinia virus Ankara boosting. Peacock JW; Nordone SK; Jackson SS; Liao HX; Letvin NL; Yafal AG; Gritz L; Mazzara GP; Haynes BF; Staats HF J Virol; 2004 Dec; 78(23):13163-72. PubMed ID: 15542668 [TBL] [Abstract][Full Text] [Related]
75. Topical application of HIV DNA vaccine with cytokine-expression plasmids induces strong antigen-specific immune responses. Liu LJ; Watabe S; Yang J; Hamajima K; Ishii N; Hagiwara E; Onari K; Xin KQ; Okuda K Vaccine; 2001 Oct; 20(1-2):42-8. PubMed ID: 11567744 [TBL] [Abstract][Full Text] [Related]
76. Safety and immunogenicity, after nasal application of HIV-1 DNA gagp37 plasmid vaccine in young mice. Hinkula J; Hagbom M; Wahren B; Schroder U Vaccine; 2008 Sep; 26(40):5101-6. PubMed ID: 18482783 [TBL] [Abstract][Full Text] [Related]
77. [Expression and immunity of multi-HIV B'/C subype genes in replicating DNA vaccines]. Gao YY; Deng Y; Qi XR; Zhang XM; Meng X; Wang HJ; Tan WJ; Ruan L Bing Du Xue Bao; 2010 May; 26(3):208-15. PubMed ID: 20572342 [TBL] [Abstract][Full Text] [Related]